Boussard & Gavaudan Investment Management »

Ani Pharmaceuticals shares owned by Boussard & Gavaudan Investment Management

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by Boussard & Gavaudan Investment Management from 13F filings

Historical chart of Boussard & Gavaudan Investment Management investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by Boussard & Gavaudan Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by Boussard & Gavaudan Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 10k 1411.48

More positions owned by Boussard & Gavaudan Investment Management

Seagate Hdd Cayman Note 3.500% 6/0
Axon Enterprise Note 0.500%12/1
Strategy Note 0.625% 9/1
Western Digital Corp Note 3.000%11/1
Chefs Whse Note 2.375%12/1
Box Note 1/1
Tyler Tex Indpt Sch Dist Note 0.250% 3/1
Burlington Stores Note 1.250%12/1
Snowflake Note 10/0
Kellogg Company (K)
Cyberark Software SHS (CYBR)
Halozyme Therapeutics Note 0.250% 3/0
Snowflake Note 10/0
Alnylam Pharmaceuticals Note 1.000% 9/1
Live Nation Entertainment In Note 3.125% 1/1

View all positions for Boussard & Gavaudan Investment Management

Top funds holding Ani Pharmaceuticals

Linden Advisors
Camden Asset Management
BlackRock
Empyrean Capital Partners
Millennium Management
Citadel Advisors
Absolute Investment Advisers
Jpmorgan Chase & Co
Lazard Asset Management
Polar Securities
Gabelli Funds
Leucadia National Corporation
Universal- Beteiligungs- und Servicegesellschaft mbH
Picton Mahoney Asset Management
FMR

View all funds holding Ani Pharmaceuticals